Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,943
Closed -$231K 2063
2025
Q4
$231K Buy
+37,943
New +$345K 0.03% 858
2023
Q4
Sell
-649
Closed -$1.59K 1838
2023
Q3
$1.59K Buy
+649
New +$1.65K ﹤0.01% 1568

Other funds holding XGN

State of Wyoming's XGN Position: Q1 2026 in Review

State of Wyoming sold out of Exagen (XGN) in Q1 2026, closing a stake of 37,943 shares — an estimated $231K sold.

State of Wyoming first reported a position in XGN in Q3 2023 and held it in 2 quarters. The position peaked at $231K in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • State of Wyoming reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 37,943 Exagen shares in Q1 2026, an estimated $231K.
  • State of Wyoming first reported a position in Exagen in Q3 2023 and held it in 2 quarters.
  • State of Wyoming's Exagen position peaked at $231K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.